Cargando…
RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
SARS-CoV-2, the virus behind the deadly COVID-19 pandemic, continues to spread globally even as vaccine strategies are proving effective in preventing hospitalizations and deaths. However, evolving variants of the virus appear to be more transmissive and vaccine efficacy toward them is waning. As a...
Autores principales: | Vesuna, Farhad, Akhrymuk, Ivan, Smith, Amy, Winnard, Paul T., Lin, Shih-Chao, Panny, Lauren, Scharpf, Robert, Kehn-Hall, Kylene, Raman, Venu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453862/ https://www.ncbi.nlm.nih.gov/pubmed/36090095 http://dx.doi.org/10.3389/fmicb.2022.959577 |
Ejemplares similares
-
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
por: Tantravedi, Saritha, et al.
Publicado: (2018) -
Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation
por: Kerr, Candace L., et al.
Publicado: (2019) -
NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3
por: Xie, Min, et al.
Publicado: (2015) -
Role of DDX3 in the pathogenesis of inflammatory bowel disease
por: Tantravedi, Saritha, et al.
Publicado: (2017) -
Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells
por: Botlagunta, Mahendran, et al.
Publicado: (2011)